The Return Of Big Pharma? 2011 Novel Approvals Could Show Payoff Of Licensing And Acquisition Strategies
By
Bridget Silverman / Email the Author / Pharmaceutical Approvals Monthly February 2011, Vol. 16, No. 2
New Drug Reviews / Word Count: 2879 / Article # 06110201030
Executive Summary
Familiar faces and familiar indications dominate the slate of novel drug candidates in line for FDA action in 2011, a change from recent years.
$125.00
Buy Now
For $125.00, purchase this 2879-word article and receive immediate online access. 100% Satisfaction Guarantee.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.